Can Ativan 1mg Be Cut into 3/4?
Yes, lorazepam (Ativan) 1mg tablets can be physically cut into 3/4 portions (0.75mg), and this approach is actually consistent with recommended benzodiazepine tapering strategies that emphasize gradual dose reductions based on percentages of the current dose.
Practical Considerations for Splitting
- Lorazepam tablets are typically scored or can be split with a pill cutter, making a 3/4 division feasible for dose reduction 1
- Reducing by 25% (from 1mg to 0.75mg) aligns with standard tapering protocols that recommend 10-25% reductions of the current dose every 1-2 weeks 1
- The reduction should always be calculated as a percentage of the current dose, not the original starting dose, to prevent disproportionately large final decrements 1
Critical Safety Framework
Abrupt discontinuation of benzodiazepines is never appropriate and can cause seizures and death—equivalent to suddenly stopping antihypertensives or antihyperglycemics 1. Any dose adjustment must be part of a gradual tapering plan 2, 3.
Key Warnings for Patients with Benzodiazepine History:
- Withdrawal seizures can occur even with therapeutic doses used for as little as 15 days, though they are more common with long-term use at high doses 2
- Seizures have been reported with short, medium, and long half-life benzodiazepines if discontinued abruptly 2
- Patients with a history of withdrawal seizures should be referred to a specialist immediately rather than managed in primary care 1
Recommended Tapering Approach
If cutting to 3/4 tablet is part of a taper:
- For patients on benzodiazepines less than 1 year: reduce by 10-25% of the current dose every 1-2 weeks 1
- For patients on benzodiazepines more than 1 year: slow to 10% of the current dose per month to minimize withdrawal symptoms 1
- The taper rate must be determined by the patient's tolerance, not a rigid schedule—pauses are acceptable and often necessary when withdrawal symptoms emerge 1
- Expect a minimum duration of 6-12 months for safe tapering 1
Monitoring Requirements
- Follow up at least monthly during the taper, with more frequent contact during difficult phases 1
- Monitor for withdrawal symptoms including anxiety, tremor, insomnia, sweating, tachycardia, headache, weakness, muscle aches, nausea, confusion, and seizures 1, 2
- Clinically significant withdrawal symptoms signal the need to further slow the taper rate 1
Common Pitfalls to Avoid
- Never use straight-line percentage reductions from the starting dose—this subjects patients to disproportionately large final decrements 1
- Never abandon the patient even if tapering is unsuccessful; maintain the therapeutic relationship 1
- Caution should be exercised in patients with a history of chronic benzodiazepine use, as they are at higher risk for withdrawal complications 4
Adjunctive Support
- Cognitive behavioral therapy (CBT) during the taper significantly increases success rates and should be incorporated 1, 5
- Consider gabapentin (starting 100-300mg at bedtime, titrating by 100-300mg every 1-7 days) to help mitigate withdrawal symptoms 1
- Patient education about benzodiazepine risks and benefits of tapering improves outcomes and engagement 1